Glaucoma Services, L. V. Prasad Eye Institute, Patia, Bhubaneswar, India.
Department of Clinical Epidemiology and Bio-Statistics, L. V. Prasad Eye Institute, Hyderabad, India.
Int Ophthalmol. 2020 Jun;40(6):1359-1366. doi: 10.1007/s10792-020-01301-y. Epub 2020 Feb 20.
To compare the outcomes of Ahmed glaucoma valve (AGV) pediatric FP8 versus the large-sized adult FP7 implants in an adult secondary glaucoma.
Patients who underwent AGV implantation from January 2011 to December 2016 for adult secondary glaucoma (due to causes other than post-vitreoretinal/buckle surgery glaucoma) with a follow-up of 6 months were included for this retrospective study. Success was defined as IOP > 6 mm Hg and < 21 mm Hg without any loss of vision, with or without the need of anti-glaucoma medications or additional procedures for control of IOP. Hypertensive phase was defined as IOP > 21 mmHg at any visit in the first 6 months of postoperative follow-up period, while failure was defined as IOP > 21 mm Hg even after medications or additional procedures, need of removal of implant or loss of light perception. Cumulative survival rates and intraoperative or postoperative complications along with IOP profiles were compared between the implants.
Of 43 patients, 19 patients underwent FP7 and 24 patients underwent FP8 Ahmed Glaucoma valve implantation. The IOP significantly reduced in both groups from baseline (31 ± 8.2 mm Hg in FP7 eyes and 37 ± 13.1 mm Hg in FP8 eyes) by a mean of 64 ± 23.5% in FP8 and 64 ± 21.5% in FP7 group, respectively, p = 0.8 with comparable final IOP of 16.5 mm Hg and 16.9 mm Hg, respectively, p = 0.9. Both groups had 75% qualified success rates at 20 months after surgery with similar rates of need for postoperative medications or incidence of hypertensive phase. The FP8 eyes had more frequent conjunctiva-related complications in eyes with prior surgeries and preoperative conjunctival scarring while the other complications were similar in the two groups.
Surgical outcomes of adult FP7 and pediatric FP8 AGV in adult secondary glaucoma seem to achieve similar IOP control and success rates. This suggests that smaller-sized FP8 can be used in adult glaucoma with good surgical outcomes albeit with careful case selection in eyes with extensive preoperative scarring to avoid conjunctival thinning-related complications postoperatively.
比较 Ahmed 青光眼引流阀(AGV)儿童 FP8 与成人 FP7 大尺寸植入物在成人继发性青光眼的疗效。
本回顾性研究纳入了 2011 年 1 月至 2016 年 12 月因玻璃体视网膜/巩膜扣带术后以外的原因导致的成人继发性青光眼(高眼压症)而接受 AGV 植入术的患者,随访 6 个月。成功定义为眼压(IOP)>6mmHg 且<21mmHg,无视力丧失,无需抗青光眼药物或其他眼压控制措施。高血压期定义为术后 6 个月内任何一次随访时 IOP>21mmHg,而失败定义为即使使用药物或其他措施后 IOP>21mmHg,需要取出植入物或丧失光感。比较两种植入物的累积存活率和术中或术后并发症以及 IOP 曲线。
43 例患者中,19 例接受 FP7 植入,24 例接受 FP8 Ahmed Glaucoma valve 植入。两组患者的 IOP 均从基线时显著降低(FP7 眼为 31±8.2mmHg,FP8 眼为 37±13.1mmHg),FP8 组降低 64±23.5%,FP7 组降低 64±21.5%,p=0.8,最终 IOP 分别为 16.5mmHg 和 16.9mmHg,p=0.9。两组患者术后 20 个月时的合格成功率均为 75%,术后需要药物治疗或发生高血压期的比例相似。FP8 眼在既往手术和术前结膜瘢痕患者中更频繁发生与结膜相关的并发症,而其他并发症在两组中相似。
成人继发性青光眼成人 FP7 和儿童 FP8 AGV 的手术结果似乎能够达到相似的眼压控制和成功率。这表明,较小尺寸的 FP8 可用于成人青光眼,具有良好的手术效果,但在术前广泛瘢痕形成的情况下,应谨慎选择病例,以避免术后与结膜变薄相关的并发症。